Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma

International Journal of Colorectal Disease

Volumn 26, Issue 2, 2011, Pages 201-210

  Vercellino, Laetitia ^a,c   Montravers, Françoise ^a   De Parades, Vincent ^b   Huchet, Virginie ^a   Kerrou, Khaldoun ^a   Bauer, Pierre ^b   Touboul, Emmanuel ^a   Talbot, Jean Noël ^a,c  

^a SORBONNE UNIVERSITÉ   (France)

^b GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

^c HÔPITAL TENON   (France)

Author keywords

Anal carcinoma; Diagnostic performance; FDG; Impact on management; PET CT

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ANUS CARCINOMA; ANUS SURGERY; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79951722954     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-010-1080-9     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008 CA. CA: A Cancer Journal for Clinicians 58:71-96
2. Johnson LG, Madeleine MM, Newcomer LM et al (2004) Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101:281-288
3. Welton ML, Sharkey FE, Kahlenberg MS (2004) The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am 13:263-275 (Pubitemid 38609353)
4. Fleshner PR, Chalasani S, Chang GJ et al (2008) Practice parameters for anal squamous neoplasms. Dis Colon Rectum 51:2-9
5. Goldman S, Norming U, Svensson C et al (1991) Transanorectal ultrasonography in the staging of anal epidermoid carcinoma. Int J Colorectal Dis 6:152-157
6. Scherrer A, Reboul F, Martin D et al (1990) CT of malignant anal canal tumors. Radiographics 10:433-453
7. Roach SC, Hulse PA, Moulding FJ et al (2005) Magnetic resonance imaging of anal cancer. Clin Radiol 60:1111-1119 (Pubitemid 41372366)
8. Damin DC, Rosito MA, Gus P et al (2003) Sentinel lymph node procedure in patients with epidermoid carcinoma of the anal canal: early experience. Dis Colon Rectum 46:1032-1037 (Pubitemid 36992984)
9. Sato H, Koh PK, Bartolo DC (2005) Management of anal canal cancer. Dis Colon Rectum 48:1301-1315 (Pubitemid 40897880)
10. Gérard JP, Chapet O, Samiei F et al (2001) Management of inguinal lymph node metastases in patients with carcinoma of the anal canal. Cancer 92:77-84
11. Das P, Bhatia S, Eng C et al (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68:794-800 (Pubitemid 46818735)
12. Ghouti L, Houvenaeghel G, Moutardier V et al (2005) Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum 48:16-22 (Pubitemid 40895652)
13. Christensen AF, Nielsen MB, Svendsen LB et al (2006) Three-dimensional anal endosonography may improve detection of recurrent anal cancer. Dis Colon Rectum 49:1527-1532 (Pubitemid 44796121)
14. Shankar LK, Hoffman JM, Bacharach S et al (2006) Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 47:1059-1066 (Pubitemid 46939960)
15. Trautmann TG, Zuger JH (2005) Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 7:309-313
16. Anderson C, Koshy M, Staley C et al (2007) PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 69:155-162 (Pubitemid 47247507)
17. Cotter SE, Grigsby PW, Siegel BA et al (2006) FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65:720-725 (Pubitemid 43795859)
18. Nguyen BT, Joon DL, Khoo V et al (2008) Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol 87:376-382
19. de Winton E, Heriot AG, Ng M et al (2009) The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 100:693-700
20. Schwarz JK, Siegel BA, Dehdashti F et al (2008) Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 71:180-186 (Pubitemid 351492591)
21. Meta J, Seltzer M, Schiepers C et al (2001) Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med 42:586-590 (Pubitemid 32298278)
22. Mistrangelo M, Pelosi E, Bellò M et al (2010) Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys 77(1):73-78
23. van Waarde A, Cobben DC, Suurmeijer AJ et al (2004) Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med 45:695-700 (Pubitemid 47618601)
24. Grigsby PW (2009) FDG-PET/CT: new horizons in anal cancer. Gastroentérol Clin Biol 33:456-458
25. Mai SK, Welzel G, Hermann B et al (2009) Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Strahlenther Onkol 185:254-259
26. Iagaru A, Kundu R, Jadvar H et al (2009) Evaluation by (18)FFDG-PET of patients with anal squamous cell carcinoma. Hell J Nucl Med 12:26-28